Fig. 6

Immune infiltration of ALOX5AP (A), CD74 (B), and FCGR2A (C) in different cancer types, such as SARC (sarcoma), OV (ovarian serous cystadenocarcinoma), LUSC (lung squamous cell carcinoma), LIHC (liver hepatocellular carcinoma), and BRCA (breast invasive carcinoma)